Kurs Lansen Pharmaceutical Holdings Limited
Aktien
A1CX37
KYG5380M1033
503
Pharmazeutika
Manager | Titel | Alter | Seit |
---|---|---|---|
Li Chen
CEO | Chief Executive Officer | 62 | 01.03.18 |
Kai Fai Pang
SEC | Corporate Secretary | - | 13.06.19 |
Yu Zhao
HRO | Human Resources Officer | 51 | 11.12.15 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Ching Har Chan
BRD | Director/Board Member | 67 | 10.02.22 |
Zhen Tao Wu
CHM | Chairman | 70 | 30.03.17 |
Kee Huen Chan
BRD | Director/Board Member | 72 | 09.04.10 |
% 1. Jan. | Kap. | |
---|---|---|
+33,46 % | 701 Mrd. | |
+26,24 % | 571 Mrd. | |
+0,93 % | 381 Mrd. | |
+21,03 % | 334 Mrd. | |
+17,51 % | 319 Mrd. | |
+0,74 % | 210 Mrd. | |
+2,95 % | 210 Mrd. | |
-6,05 % | 201 Mrd. | |
-3,61 % | 157 Mrd. |